ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Microbial Physiology and Metabolism
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1604639
Genome Mining and OSMAC Strategies Unveil Diverse Secondary Metabolites from the Endophytic Fungus Diaporthe kyushuensis ZMU-48-1 with Antifungal Activity
Provisionally accepted- Zunyi Medical University, Zunyi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Fungal-derived bioactive natural products are a crucial resource for drug discovery; however, under standard laboratory cultivation conditions, fungi predominantly yield known and repetitively isolated metabolites. This metabolic constraint presents a major obstacle to the discovery of structurally novel and bioactive secondary metabolites. Recent advances in whole-genome sequencing have revealed that a significant portion of fungal biosynthetic gene clusters (BGCs) remain silent or unexpressed under conventional culture conditions, underscoring the importance of activating these cryptic BGCs. In this study, we systematically explored the biosynthetic potential of the terrestrial-derived fungus Diaporthe kyushuensis ZMU-48-1, which was isolated from decayed leaves of Acacia confusa Merr., by integrating genome mining with the one-strain-many-compounds (OSMAC) strategy. Whole-genome sequencing and antiSMASH analysis identified 98 BGCs, of which approximately 60% exhibited no significant homology to known clusters, highlighting their potential novelty. The optimization of culture conditions via the OSMAC approach revealed that Potato Dextrose Broth (PDB) supplemented with 3% NaBr, PDB supplemented with 3% sea salt, and rice solid medium were optimal for increasing metabolite diversity. Large-scale fermentation and chromatographic separation yielded 18 structurally diverse compounds, including two novel pyrrole derivatives, kyushuenines A (1) and B (2), alongside 16 known secondary metabolites. Antifungal assays demonstrated that compound 8 exhibited activity against Bipolaris sorokiniana (MIC = 200 μg/mL), whereas compound 18 displayed potent inhibition of Botryosphaeria dothidea (MIC = 50 μg/mL), underscoring their potential as antifungal agents. These findings underscore the untapped chemical diversity of D. kyushuensis and its potential as a resource for drug discovery.
Keywords: Diaporthe kyushuensis, genome mining, Natural Products, Biosynthetic gene clusters, Antifungal activity
Received: 02 Apr 2025; Accepted: 26 May 2025.
Copyright: © 2025 Zheng, Wang, Wang, Zeng, Yuan and Yin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Siwen Yuan, Zunyi Medical University, Zunyi, China
Tianpeng Yin, Zunyi Medical University, Zunyi, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.